1. What Sanofi might buy with its Regeneron windfall — Gilead pens $2B Arcus pact for immuno-oncology targets — FDA approves BMS Opdivo + Yervoy combo for first-line on certain types of NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Cafepharma Playground

There is more to life than your job, so come to the Cafepharma Playground when you need a break and want to talk about whatever is on your mind. Registered posting only


Sort By:
Title
Replies ↓ Views
Last Message
  1. Breakingnews
    Replies:
    5,093
    Views:
    349,507
  2. Anonymous
    Replies:
    1,860
    Views:
    228,898
  3. Pale Horse
    Replies:
    626
    Views:
    28,660
  4. leonidas
    Replies:
    510
    Views:
    22,577
  5. Drug Dumper
    Replies:
    349
    Views:
    13,213
  6. Man For All Seasons
    Replies:
    313
    Views:
    13,141
  7. Breakingnews
    Replies:
    302
    Views:
    39,249
  8. hypnotistcollector
    Replies:
    270
    Views:
    11,371
  9. Anonymous
    Replies:
    253
    Views:
    7,157
  10. Anonymous
    Replies:
    218
    Views:
    17,569
  11. Drug Dumper
    Replies:
    177
    Views:
    30,654
  12. jasmin
    Replies:
    177
    Views:
    4,905
  13. Pale Horse
    Replies:
    138
    Views:
    4,688
  14. Anonymous
    Replies:
    128
    Views:
    6,052
  15. leonidas
    Replies:
    127
    Views:
    4,689
  16. GorgeousGAMS
    Replies:
    121
    Views:
    3,673
  17. Mr. Hamster
    Replies:
    118
    Views:
    5,076
  18. Man For All Seasons
    Replies:
    118
    Views:
    3,403
  19. Drug Dumper
    Replies:
    117
    Views:
    4,361
  20. Pale Horse
    Replies:
    116
    Views:
    4,676

Thread Display Options

Loading...